You are here

  • Home
  • Archive
  • Volume 78, Issue 8
  • Association between use of non-steroidal anti-inflammatory drugs and risk of myocardial infarction in patients with spondyloarthritis and osteoarthritis

Article Text

Article menu

Download PDFPDF

Correspondence
Association between use of non-steroidal anti-inflammatory drugs and risk of myocardial infarction in patients with spondyloarthritis and osteoarthritis
Free
  1. Jian Zhou1,2,
  2. Ying Xiao3,
  3. Chenxi Li4,
  4. Tang Liu1,
  5. Wanchun Wang1
  1. 1 Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, China
  2. 2 Department of Sports Medicine Research Center, Central South University, Changsha, Hunan, China
  3. 3 Department of Nephrology, The Second Xiangya Hospital, Central South University, Changsha, China
  4. 4 Department of Clinical Medicine, School of Medicine, Shandong University, Jinan, Shandong, China
  1. Correspondence to Professor Tang Liu and Professor Wanchun Wang, Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China; liutang1204{at}csu.edu.cn, wanchun.wang{at}csu.edu.cn

https://doi.org/10.1136/annrheumdis-2018-213752

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Non-steroidal anti-inflammatory drugs (NSAIDs) have anti-inflammatory, antipyretic and analgesic effects and are widely used clinically for the treatment of osteoarthritis (OA), rheumatoid arthritis (RA) and many other inflammatory diseases.1 At present, NSAIDs are the first-line therapy for psoriatic arthritis and axial spondyloarthritis  (SpA),2–4 but the use of NSAIDs may be related to the risk of myocardial infarction (MI).5 6 Recently, we read with great interest the paper entitled ‘Risk of myocardial infarction with use of selected non-steroidal anti-inflammatory drugs in patients with spondyloarthritis and osteoarthritis’ published online in 19 April 2018 in Annals of the Rheumatic Diseases. Dubreuil et al concluded that compared with remote use of any NSAIDs, the use of diclofenac in SpA was related to twofold to threefold risk of MI, but the use of naproxen did not increase the risk of MI in OA or SpA.7 Certainly, the findings of Dubreuil et al will be significant for clinicians, while there are still several questions that we would like to communicate with the …

    View Full Text

    Linked Articles